← Eichor
Study identifier: NCT07554118 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Postural Control in Adults

Condition: Older · Adults · Older Adults, Balance  ·  Sponsor: University of Oklahoma

PhaseNA
Planned participants30
Who can joinAll sexes, 65 Years to 80 Years
Healthy volunteersYes

About this study

The investigators propose a 2-week intervention involving adults over 65 years old. Participants will undergo dynamic balance training on an movable platform (stabilometer) with either restricted or full vision. The primary objective is to facilitate sensory re-weighting, hypothesizing that restricted vision training will increase somatosensory input utilization for postural control. Pre- and post-training assessments will measure postural control during gait initiation under a dual-task condition. The investigators hypothesize that the restricted vision group will demonstrate: 1. Improved postural control, indicated by increased center of pressure displacement during gait initiation. 2. Improved ability to utilize somatosensory input during a balance task.

This description comes directly from the study's public registry record.

Talk to the study team

Yo Shih, PhD  ·  405-271-2131  ·  Yo-shih@ou.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Oklahoma Health Sciences CenterOklahoma City, Oklahoma, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07554118